Management of prepregnancy, pregnancy, and postpartum obesity from the FIGO Pregnancy and Non-Communicable Diseases Committee: A FIGO (International Federation of Gynecology and Obstetrics) guideline

Int J Gynaecol Obstet. 2020 Sep;151 Suppl 1(Suppl 1):16-36. doi: 10.1002/ijgo.13334.

Fionnuala M McAuliffe¹, Sarah Louise Killeen¹, Chandni Maria Jacob^{2

3}, Mark A Hanson^{2

3}, Eran Hadar^{4

5}, H David McIntyre⁶, Anil Kapur⁷, Anne B Kihara^{8

9}, Ronald C Ma^{10

11}, Hema Divakar¹², Moshe Hod^{13

14}

¹ UCD Perinatal Research Centre, School of Medicine, National Maternity Hospital, University College Dublin, Dublin, Ireland.
² Institute of Developmental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
³ NIHR Southampton Biomedical Research Centre, University Hospital Southampton, Southampton, UK.
⁴ Maternal-Fetal Medicine Unit, Rabin Medical Center, Petach-Tikva, Israel.
⁵ Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel.
⁶ Mater Research, The University of Queensland, South Brisbane, Qld, Australia.
⁷ World Diabetes Foundation, Bagsvaerd, Denmark.
⁸ African Federation of Obstetricians and Gynaecologists, Khartoum, Sudan.
⁹ Department of Obstetrics and Gynecology, School of Medicine, University of Nairobi, Nairobi, Kenya.
¹⁰ Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China.
¹¹ Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong SAR, China.
¹² Divakars Speciality Hospital, Bengaluru, India.
¹³ Mor Comprehensive Women's Health Care Center, Tel Aviv, Israel.
¹⁴ FIGO Pregnancy and Non-Communicable Diseases Committee, International Federation of Gynecology and Obstetrics, London, UK.

No abstract available

Publication types